Mice Showed Hyperactivity and Paw Tremors During THC Withdrawal | Research

The takeaway

Mice chronically treated with THC and then given a CB1 blocker showed hyperlocomotion (4x normal activity) and paw tremors as quantifiable withdrawal signs.

Read this if you are interested in the biology of cannabis withdrawal or dependence research.

4.1x locomotor activity and 100-fold increase in paw tremors during THC withdrawal

What the researchers found

C57BL/6 mice received THC (25 mg/kg) or vehicle twice daily for 4.5 days. The CB1 receptor antagonist SR141716 (rimonabant) was then administered to precipitate withdrawal.

THC-treated mice showed dramatically increased locomotor activity: total activity was 4.1 times, ambulatory activity 3.3 times, and stereotypic activity 3.8 times that of vehicle-treated controls.

Paw tremors were even more dramatic: THC-treated mice showed 111 paw tremors in 45 minutes versus only 1.1 in controls.

Interestingly, scratching behavior showed the opposite pattern: vehicle-treated mice scratched 182 times versus only 17 times in THC-treated mice.

This was the first study to demonstrate hyperlocomotion as an explicit THC withdrawal sign in mice.

Why it matters

Establishing reliable, quantifiable withdrawal signs in animal models is essential for studying the mechanisms of cannabis dependence and developing potential treatments.

The numbers in context

THC dose: 25 mg/kg twice daily for 4.5 days. Total locomotor activity: 4.1x control. Ambulatory activity: 3.3x. Stereotypic activity: 3.8x. Paw tremors: 111 vs 1.1 in 45 minutes. Scratching: 17 vs 182 (reversed direction).

How the study worked

C57BL/6 mice received twice-daily subcutaneous THC (25 mg/kg) or vehicle for 4.5 days. Four hours after the last dose, SR141716 (15 mg/kg) was administered to precipitate withdrawal. Locomotor activity and specific behaviors were recorded for 2 hours.

What this study cannot tell us

Animal withdrawal was precipitated by an antagonist rather than occurring naturally through abstinence. THC doses were much higher relative to body weight than typical human use. Mouse behavior may not directly model human withdrawal experiences.

How to read the evidence

Preclinical animal study using precipitated (not spontaneous) withdrawal in a single mouse strain.

When this study was published

Published in 2009. Cannabis withdrawal has since been formally recognized in diagnostic manuals, and animal models continue to be refined.

The bigger picture

Cannabis withdrawal has been increasingly recognized as clinically significant in humans. Animal models with clear, measurable withdrawal signs allow researchers to investigate the neurobiology of dependence and test potential pharmacological interventions.

Questions still open

Do these same withdrawal mechanisms operate in humans? Would the hyperlocomotion seen in mice correspond to the restlessness reported by humans during cannabis withdrawal? Can these quantifiable signs be used to screen potential withdrawal treatments?

Common questions

What does precipitated withdrawal mean?

Instead of waiting for THC to leave the system naturally, researchers administered a CB1 receptor blocker (rimonabant) to immediately reverse THC effects, triggering rapid withdrawal. This produces more consistent and dramatic withdrawal signs than natural abstinence.

Do humans experience similar withdrawal symptoms?

Human cannabis withdrawal includes irritability, sleep difficulties, restlessness, and decreased appetite. The hyperlocomotion in mice may correspond to the restlessness and agitation humans report, though direct comparisons between mouse and human behavior require caution.

Read the original research

Hyperlocomotion and paw tremors are two highly quantifiable signs of SR141716-precipitated withdrawal from delta9-tetrahydrocannabinol in C57BL/6 mice.

Neuroscience letters, 465(1), 66-70

View on PubMed ↗Publisher’s paper ↗

Citation

Huang, Peng; Liu-Chen, Lee-Yuan; Unterwald, Ellen M; Cowan, Alan. (2009). Hyperlocomotion and paw tremors are two highly quantifiable signs of SR141716-precipitated withdrawal from delta9-tetrahydrocannabinol in C57BL/6 mice.. Neuroscience letters, 465(1), 66-70. https://doi.org/10.1016/j.neulet.2009.08.073